FinanceAYR Wellness Has No Estimate for Q1 2025 Interim Filings; Trading Remains on HoldThe cannabis company’s delay in filing its financial statements comes as its negotiations with creditors remain ongoing.AYR Wellness Inc.Posted by CBT StaffJune 27, 2025RecommendedCanopy Growth Agrees to Make 3 Prepayments to Reduce Term Loan by $50 MillionAYR Wellness Further Extends Limited Waiver Agreement With Senior NoteholdersLEEF Brands Announces CAD $1 Million Private PlacementGlass House Brands Announces Preferred Equity RefinancingRelated StoriesAurora Cannabis Denies 2nd ‘False’ News Report of Acquisition of MedLeaf TherapeuticsVireo Growth Provides Corporate Update After Closing All Merger TransactionsAYR Fails to Complete Q1 2025 Interim Financial Filings; Cease-Trade Order Remains in EffectAYR Wellness Issued Cease Trade Order by Ontario Securities Commission